Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2024-12-31 00:00:00 ET · period of report 2024-12-27 · accession 0000950170-24-141597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-12-31 | 2024-12-27 | RLAY | Catinazzo Thomas | CFO | S - Sale | $4.42 | -4,865 | 303.8K | -2% | -$21.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | S | D | 4,566 | $4.42 | 299,226 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $4.37 to $4.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 291,498 shares underlying RSUs. |
| 2 | Common | Common Stock | 2024-12-27 | S | D | 299 | $4.38 | 303,792 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 291,498 shares underlying RSUs. |